RxDoctor Payments Data

Pius Ehiane, APRN

Psychiatric/Mental Health · North Las Vegas, NVNPI 1962801951

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 227 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,812in general payments, 2019–2025

Across 227 payments — averaging $21.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$922
  • Alkermes, Inc.$790
  • AbbVie$753
  • Otsuka America Pharmaceutical, Inc.$455
  • Johnson & Johnson$434
  • E.r. Squibb & Sons, L.L.C.$309
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$4,812100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,812 in reported general payments places this provider in the 90th percentile of 362 psychiatric/mental health providers in Nevada.

See all psychiatric/mental health providers in Nevada

Medicare billing

Part B allowed, 2024
$9,277
Medicare patients
12
Services billed
147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Quetiapine Fumarate30$569
Hydroxyzine Hcl24$508
Mirtazapine18$466
Duloxetine Hcl20$292
Trazodone Hcl29$247
Hydroxyzine Pamoate24$242
Venlafaxine Hcl ErVenlafaxine Hcl36$227
Topiramate12$174
Clonazepam44$145
Bupropion Hcl SrBupropion Hcl12$87
Fluoxetine Hcl11$28
Lamotrigine15$16

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in North Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →